Role of interleukin 6 in the growth of myelomaderived cell lines
- 31 October 1992
- journal article
- Published by Elsevier in Leukemia Research
- Vol. 16 (10) , 951-959
- https://doi.org/10.1016/0145-2126(92)90073-g
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Role of the CD28 receptor in T-cell activationImmunology Today, 1990
- Serum levels of interleukin 6, a potent myeloma cell growth factor, as a reflect of disease severity in plasma cell dyscrasias.Journal of Clinical Investigation, 1989
- Phenotypic and functional characterization of normal and malignant terminal B (plasma) cellsEuropean Journal of Haematology, 1989
- Interleukin 6 gene expression in normal and neoplastic B cells.Journal of Clinical Investigation, 1989
- Establishment of two interleukin 6 (B cell stimulatory factor 2/interferon beta 2)-dependent human bone marrow-derived myeloma cell lines.The Journal of Experimental Medicine, 1989
- Novel type of proliferating lymphoplasmacytoid cell with a characteristic spotted immunofluorescence pattern.Journal of Clinical Investigation, 1987
- Production of hybridoma growth factor by human monocytesEuropean Journal of Immunology, 1987
- A monoclonal antibody reactive with a subset of human plasma cellsBritish Journal of Haematology, 1986
- Idiotype‐bearing and antigen‐binding receptors produced by blood T lymphocytes in a case of human myelomaEuropean Journal of Immunology, 1977
- Plasma cell surface antigen on human blood lymphocytesNature, 1974